Description
Overview
Insulin-Like Growth factor-1 is a naturally occurring form of IGF-1 (Insulin-like Growth Factor-1). It is used in the treatment of growth failure in children and IGF-1 deficiency, or growth hormone deficiency. IGF-1 DES (Insulin-Like Growth Factor 1, DES) comes in 1mg/vial subcutaneous injections which contain 1mg of Insulin-Like Growth Factor 1, DES and excipients.
IGF-1 DES (Insulin-Like Growth Factor 1, DES) Mechanism of Action
As an analog of IGF-1, IGF-1 DES mediates the effect of growth hormone although it is more potent than IGF-1. It binds to the IGF1 receptor to promote growth in almost every part of the body. It also signals several growth pathways that result in increased growth and it inhibits the pathway of cellular death. Naturally, growth hormone stimulates the release of IGF-1 from the liver. However, IGF-1 DES can act in the absence of growth hormone which makes it useful in treating growth hormone deficiency and resistance.
IGF-1 DES (Insulin-Like Growth Factor 1, DES) Dosage
As directed by the physician.
IGF-1 DES (Insulin-Like Growth Factor 1, DES) Side Effects
Hypoglycemia, retina swelling, muscle pain, joint pain bell’s palsy.
IGF-1 DES (Insulin-Like Growth Factor 1, DES) Interactions
Macimorelin.
Composition
✓ Insulin-Like Growth Factor 1, DES . . . 1mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s




![DEUSTROPIN 4/12 (Recombinant Human Growth Hormone [rDNA origin])](https://www.peakbiopeptides.com/wp-content/uploads/2025/11/DEUSTROPIN--300x300.webp)
Reviews
There are no reviews yet.